$1m boost to progress fungal disease treatment
March 19, 2026
March 19, 2026
MELBOURNE, Australia, March 19 -- La Trobe University issued the following news release:
* * *
$1m boost to progress fungal disease treatment
*
Deftbiotech, a La Trobe University-based spin-out company, has been established to progress the development of a new anti-fungal drug called Pezadeftide, which showed promise as a topical treatment for fungal nail disease during Phase 1 trials.
The investment from Eagle Fund, to which La T . . .
* * *
$1m boost to progress fungal disease treatment
*
Deftbiotech, a La Trobe University-based spin-out company, has been established to progress the development of a new anti-fungal drug called Pezadeftide, which showed promise as a topical treatment for fungal nail disease during Phase 1 trials.
The investment from Eagle Fund, to which La T . . .